申请人:METABOMED LTD.
公开号:US10851064B2
公开(公告)日:2020-12-01
The present invention relates to novel ACSS2 inhibitors having activity as anti-cancer therapy, treatment of alcoholism, and viral infection (e.g., CMV), composition and methods of preparation thereof, and uses thereof for treating viral infection, alcoholism, alcoholic steatohepatitis (ASH), non-alcoholic steatohepatitis (NASH), obesity/weight gain, anxiety, depression, post-traumatic stress disorder, inflammatory/autoimmune conditions and cancer, including metastatic cancer, advanced cancer, and drug resistant cancer of various types.
本发明涉及具有抗癌疗法、治疗酒精中毒和病毒感染(如CMV)活性的新型ACSS2抑制剂、其组合物和制备方法,以及其在治疗病毒感染、酒精中毒、酒精性脂肪性肝炎(ASH)、非酒精性脂肪性肝炎(NASH)中的用途、CMV)、其组合物和制备方法,以及其在治疗病毒感染、酗酒、酒精性脂肪性肝炎(ASH)、非酒精性脂肪性肝炎(NASH)、肥胖/体重增加、焦虑、抑郁、创伤后应激障碍、炎症/自身免疫性疾病和癌症(包括转移性癌症、晚期癌症和各种类型的耐药性癌症)方面的用途。